The Effects of dexmedetomidine added to Levobupivacaine for rectus sheath block.
Not Applicable
Recruiting
- Conditions
- colon cancer
- Registration Number
- JPRN-UMIN000018025
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)patient who did not have the block 2)patient who had an allergy to local anesthetics 3)patient who refused to join the study 4)patient who was judged as inadequite
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain score
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain the adjuvant effect of dexmedetomidine on levobupivacaine in rectus sheath block for colon cancer surgery?
How does the combination of dexmedetomidine and levobupivacaine compare to standard analgesic regimens in postoperative colon cancer patients?
Are there specific biomarkers that predict enhanced analgesic response when dexmedetomidine is added to levobupivacaine for rectus sheath block in abdominal surgeries?
What are the potential adverse events associated with dexmedetomidine-levobupivacaine rectus sheath block in colon cancer patients and how can they be managed?
What other adjuvants or combination therapies have shown promise in rectus sheath block for abdominal cancer surgeries compared to dexmedetomidine-levobupivacaine?